GLUE
Monte Rosa TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
GLUE vs peer average
82/100
GLUE vs. peer average (A vs. C)
Grade spread
B 2 · C 8 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ARVN is the first available peer comparator.
Broader targeted protein degradation comparator; useful for sector framing, though it is less directly comparable because of scale and mix.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
GLUE
Monte Rosa Therapeutics
ARVN
Arvinas
Grade
A
C
Momentum
75
8
Value
60
57
Sentiment
81
90
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs ARVN
GLUE / ARVN
Grade Position
Above peers
GLUE vs. peer average (A vs. C)
82/100
Momentum
75
GLUEValue
60
GLUESentiment
81
ARVNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs GLUE
ARVN is the first peer returned for this comparison set.